Tumor-associated inflammation as a potential prognostic tool in BRCA1/2-associated breast cancer

Human Pathology

Volumn 46, Issue 2, 2015, Pages 182-190

  Van Verschuer, Victorien M T ^a   Hooning, Maartje J ^a   Van Baare Georgieva, Radka D ^a,b   Hollestelle, Antoinette ^a   Timmermans, Anne M ^a   Koppert, Linetta B ^a   Verhoog, Leon C ^c   Martens, John W M ^a,d   Seynaeve, Caroline ^a   Van Deurzen, Carolien H M ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b NETHERLANDS FORENSIC INSTITUTE   (Netherlands)

^c PATHAN Pathology Laboratory   (Netherlands)

^d Cancer Genomics Center   (Netherlands)

Author keywords

BRCA1 2; Breast cancer; Prognostic features; Tumor associated inflammation; Tumor associated stroma

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BRAP PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PROGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; STROMA; TRIPLE NEGATIVE BREAST CANCER; TUMOR DIFFERENTIATION; TUMOR NECROSIS; BREAST NEOPLASMS; COMPLICATION; GENETICS; METABOLISM; MORTALITY; MUTATION; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK;

BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; INFLAMMATION; MUTATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK; UBIQUITIN-PROTEIN LIGASES;

EID: 84920946619     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.10.020     Document Type: Article

References (33)

1. M.C. King, J.H. Marks, J.B. Mandell, and New York Breast Cancer Study Group Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646
2. J.P. Struewing, P. Hartge, and S. Wacholder The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 1997 1401 1408
3. D.M. van der Kolk, G.H. de Bock, and B.K. Leegte Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age Breast Cancer Res Treat 124 2010 643 651
4. M.K. Graeser, C. Engel, and K. Rhiem Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers J Clin Oncol 27 2009 5887 5892
5. A. Antoniou, P.D. Pharoah, and S. Narod Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 2003 1117 1130
6. L. Bordeleau, S. Panchal, and P. Goodwin Prognosis of BRCA-associated breast cancer: a summary of evidence Breast Cancer Res Treat 119 2010 13 24
7. N. Mavaddat, D. Barrowdale, and I.L. Andrulis Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) Cancer Epidemiol Biomarkers Prev 21 2012 134 147
8. C.T. Brekelmans, M.M. Tilanus-Linthorst, and C. Seynaeve Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases Eur J Cancer 43 2007 867 876
9. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349 1997 1505 1510
10. M. Kriege, C.T. Brekelmans, and C. Boetes Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 2004 427 437
11. E.M. de Kruijf, J.G. van Nes, and C.J. van de Velde Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients Breast Cancer Res Treat 125 2011 687 696
12. Z.M. Mohammed, J.J. Going, J. Edwards, and D.C. McMillan The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer Cancer Treat Rev 38 2012 943 955
13. F.J. Gujam, J.J. Going, J. Edwards, Z.M. Mohammed, and D.C. McMillan The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer Crit Rev Oncol Hematol 89 2014 231 241
14. E. Honrado, J. Benitez, and J. Palacios Histopathology of BRCA1- and BRCA2-associated breast cancer Crit Rev Oncol Hematol 59 2006 27 39
15. M. Schaapveld, O. Visser, and W.J. Louwman The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands Breast Cancer Res Treat 110 2008 189 197
16. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 1991 403 410
17. A.H. Lee, C.E. Gillett, K. Ryder, I.S. Fentiman, D.W. Miles, and R.R. Millis Different patterns of inflammation and prognosis in invasive carcinoma of the breast Histopathology 48 2006 692 701
18. NABON Breast Cancer Guideline [Internet] 2002 Integraal Kankercentrum Nederland Utrecht [updated 2012 February 13th; cited 2014 April 19th. www.oncoline.nl/mammacarcinoom ]
19. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
20. E.M. Azzato, D. Greenberg, and M. Shah Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates? Br J Cancer 100 2009 1806 1811
21. M.V. Dieci, C. Criscitiello, and A. Goubar Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study Ann Oncol 25 2014 611 618
22. C. Denkert, S. Loibl, and A. Noske Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer J Clin Oncol 28 2010 105 113
23. E.A. Rakha, M. Aleskandarany, and M.E. El-Sayed The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast Eur J Cancer 45 2009 1780 1787
24. E.A. Rakha, S. Martin, and A.H. Lee The prognostic significance of lymphovascular invasion in invasive breast carcinoma Cancer 118 2012 3670 3680
25. H. Rundqvist, and R.S. Johnson Tumour oxygenation: implications for breast cancer prognosis J Intern Med 274 2013 105 112
26. M. Pistelli, A. Pagliacci, and N. Battelli Prognostic factors in early-stage triple-negative breast cancer: lessons and limits from clinical practice Anticancer Res 33 2013 2737 2742
27. E.R. Fisher, A.S. Palekar, R.M. Gregorio, C. Redmond, and B. Fisher Pathological findings from the national surgical adjuvant breast project (Protocol No. 4). IV. Significance of tumor necrosis Hum Pathol 9 1978 523 530
28. K.W. Gilchrist, R. Gray, B. Fowble, D.C. Tormey, and SGt Taylor Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients J Clin Oncol 11 1993 1929 1935
29. G.L. Semenza Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy Trends Pharmacol Sci 33 2012 207 214
30. P. van der Groep, A. Bouter, F.H. Menko, E. van der Wall, and P.J. van Diest High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer Breast Cancer Res Treat 111 2008 475 480
31. M. Yan, M. Rayoo, E.A. Takano, KConFab Investigators, and S.B. Fox BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression Br J Cancer 101 2009 1168 1174
32. L.A. Quenneville, K.A. Phillips, and H. Ozcelik HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry Cancer 95 2002 2068 2075
33. M.R. Heerma van Voss, P. van der Groep, J. Bart, E. van der Wall, and P.J. van Diest Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls BMC Cancer 10 2010 145 151